Charles York

Direttore Finanziario/CFO presso DAY ONE BIOPHARMACEUTICALS, INC.

Patrimonio netto: 3 M $ in data 30/04/2024

47 anni

Health Technology

Consumer Services

Electronic Technology

Posizioni attive di Charles York

Società	Posizione	Inizio	Fine
DAY ONE BIOPHARMACEUTICALS, INC.	Direttore operativo	01/02/2021	-
	Direttore Finanziario/CFO	01/02/2021	-
	Segretario Aziendale	01/02/2021	-
DOT Therapeutics-2, Inc. DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology DOT Therapeutics-2, Inc. develops new therapies that change the outcome for people of all ages living with cancer. The company was founded by Julie Grant and Samuel Blackman and is headquartered in South San Francisco, CA.	Direttore operativo	17/02/2021	-
	Direttore Finanziario/CFO	17/02/2021	-

Società	Posizione	Inizio	Fine
SPYRE THERAPEUTICS, INC.	Direttore Finanziario/CFO	01/07/2014	12/02/2021
	Contatto Relazioni con gli Investitori	01/07/2014	-
	Segretario Aziendale	28/09/2015	12/02/2021
ASTROTECH CO.	Comptroller/Controller/Auditor	01/03/2009	01/08/2012

University of Connecticut	Undergraduate Degree
McCombs School of Business	Masters Business Admin

Distribuzione geografica

Stati Uniti	6
	2

Posizioni

Settori

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	3
SPYRE THERAPEUTICS, INC.	Health Technology
ASTROTECH CO.	Electronic Technology
DAY ONE BIOPHARMACEUTICALS, INC.	Health Technology

Aziende private	1
DOT Therapeutics-2, Inc. DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology DOT Therapeutics-2, Inc. develops new therapies that change the outcome for people of all ages living with cancer. The company was founded by Julie Grant and Samuel Blackman and is headquartered in South San Francisco, CA.	Health Technology